-
COVID-19: The immune system can fight back
worldpharmanews
March 18, 2020
Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.
-
NTU builds chip to analyse health of immune system
biospectrumasia
September 26, 2019
The proof of concept device may one day help doctors to quickly gain insight into a person’s immune system, and spot early signs of inflammation and infection that could signal the need for further in-depth tests.
-
First Impressions Go a Long Way in the Immune System
biospectrumasia
July 28, 2019
Once tuberculosis symptoms appear, patients have to take three different antibiotics over the course of nine months and antibiotic resistance has become rampant in these bacteria.
-
Researchers develop new prognostic test for colorectal cancer
pharmatimes
March 08, 2019
High-risk stage two cancer patients could be identified more easily and accurately, due to a hopeful new prognostic method.
-
Safety Trial Finds Risk of Blood Clots in Lungs and Death with Higher Dose of Tofacitinib in RA Patients; FDA to Investigate
americanpharmaceuticalreview
February 27, 2019
The U.S. Food and Drug Administration (FDA) is alerting the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib ....
-
UCSF discover potential new treatment approach for type 1 diabetes
pharmaceutical-technology
February 26, 2019
Researchers at the University of California, San Francisco (UCSF) Diabetes Centre have uncovered evidence to suggest assumptions about the cause of type 1 diabetes are incorrect.....
-
Dementia Consortium welcomes new partners to drug discovery collaboration
pharmaceutical-technology
February 14, 2019
Charity industry partnership Dementia Consortium has announced that pharmaceutical companies, Johnson & Johnson Innovation....
-
Grey Wolf raises £10m for tumour ‘illumination’ tech
pharmaphorum
February 13, 2019
Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.
-
Researchers develop new treatment for TB
pharmaceutical-technology
January 10, 2019
A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.....
-
Pfizer partners with CytoReason on immune system models for drug discovery
pharmaceutical-technology
January 09, 2019
Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage the former’s technology to create cell-based models of the immune system.....